undamentalytics Newsletter
Sign in

Ridgetech Inc. (RDGT) stock

Add to watchlist

Add holding +

NASDAQ: RDGT Nasdaq Health Care Services

D Fundamentals grade

Ridgetech Inc. is a US-listed company in the health care services industry. Its financial year ends in March.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: share count (1m) is 0.0067x the cover-page count (133m).

Price vs value

Under review: share count (1m) is 0.0067x the cover-page count (133m). We'll show the comparison once resolved.

Ridgetech Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders1 buying, 1 selling5 purchases and 3 sales by directors and officers, last 12 monthsInsider trades
  • Funds5 adding, 0 cuttingOf 0 active managers that changed their stake, 0 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Ridgetech files

Where Ridgetech stands after its latest Filing

Revenue for the twelve months was $132m, up 10.2% on a year earlier, against a decline of 3.2% a quarter earlier. Free-cash-flow margin rose to -1.1% from -3.3% a year earlier. The diluted share count is up 96.6% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 2 of our 3 financial-health checks.

Our model value for Ridgetech is under review, so past values are not shown until it is resolved.

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Ridgetech Inc.'s trailing-twelve-month revenue grew 10.2% year on year, with a free-cash-flow margin of -1.1%. Where it stands out: change in growth rate of +13.4pp ranks 3 of 41 health care services companies we cover. Where it lags: days sales outstanding of 90 days ranks 30 of 31 health care services companies we cover.

Current signal Revenue growth accelerating: TTM revenue growth rose to 10.2% (+13.4pp vs the prior quarter).

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Growth speeding up. The growth rate is 13.4 points higher than a quarter earlier.
  • Net cash. Cash exceeds long-term debt by $0.0bn.

Things to watch

  • Loss-making. Operating margin is -1.4%: costs exceed revenue.
  • Burning cash. Free cash flow was -1.1% of revenue over the last 12 months.
  • Share dilution. Diluted shares rose 96.6% in a year.
  • Volatile shares. Over the past year the shares showed annualised volatility of 204% and a beta of 1.4 against the S&P 500.
  • Below peers: days sales outstanding. Days sales outstanding of 90 days ranks 30 of 31 health care services companies we cover (median 39 days).
  • Below peers: gross margin. Gross margin of 3.6% ranks 25 of 27 health care services companies we cover (median 29.0%).

Latest results

Earnings per share
$6119.97 against an average estimate of $6659.97: missed by 8.1%

Ridgetech's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+1.2%
  • 1 week-1.2%
  • 1 month-6.9%
  • This year-99.8%
  • 1 year-99.7%
  • 5 years-100.0%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$132M
Operating margin
-1.4%
Net margin
-0.9%
EPS (TTM, diluted)
$-17.21

Growth

Revenue growth
+10.2%
Change in growth rate
+13.4 pts
Share count change
+96.6%

Cash

Free cash flow (TTM)
-$1.4M
FCF margin
-1.1%

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

No recent updates are available for RDGT from the sources we follow. See filings →

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Ridgetech Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: share count (1m) is 0.0067x the cover-page count (133m): held for review.

Valuation multiples over time Market data may be delayed

At fiscal year end 2020202120222023202420252026
Share price$65160.00$40320.00$11520.00$13440.00$472.50$157.50$4.50
Market value$4.3bn$3.3bn$962m$1.1bn$36m$12m$327006
+ Net debt (− = net cash)−$31m$6m−$18m$10m$4m−$2m−$18m
Enterprise value$4.2bn$3.3bn$944m$1.1bn$41m$9m−$18m
Multiples
Price / sales 36.5x24.7x5.9x9.1x0.3x0.1x0.0x
Price / earnings —————1.1x—
Price / free cash flow —————10.7x—
EV / EBITDA ————29.3x90.7x—

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

No analyst estimates are published for Ridgetech Inc.: too few analysts cover it.

Earnings against estimates

Quarter toEstimateActualSurprise
Dec 2010 $6659.97 $6119.97 −8.1%
Sept 2010 $6119.97 $4319.98 −29.4%
Jun 2010 $5399.98 $6119.97 +13.3%

Adjusted EPS as companies report it, against the average analyst estimate.

Positioning

Short interest
4.8%
of tradable shares
Days to cover
0.36
at average volume
Short interest, 1 month
−29%
to October 15, 2026
Held by institutions
4%
of shares
Held by insiders
0.4%
of shares
Employees
64
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
RDGT−62%−22%−94%−60%+61%−100%
Industry peers (median)−1%−28%+8%−6%−9%+15%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
RDGT33%50%25%33%67%36%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
RDGT−76%−67%−98%−71%−64%−100%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 3, 2015: 100% from May 27, 2020 to August 5, 2026. Getting back needed a 16985816% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$0.71 – $760.50
From 52-week high
−99.9%
vs 50-day average
−7.6%
vs 200-day average
−98.8%
Volatility (1 year)
204%
Beta vs S&P 500
1.37

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Ridgetech Inc. in five measures

Fundamentals grade D
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Ridgetech Inc.
$100M $120M $140M $160M $180M FY20 Q4 FY22 Q4 FY24 Q4 FY26 Q4 Revenue (TTM), FY20 Q4: $117.3M Revenue (TTM), FY21 Q4: $133.1M Revenue (TTM), FY22 Q4: $164.4M Revenue (TTM), FY23 Q4: $120.2M Revenue (TTM), FY24 Q4: $124M Revenue (TTM), FY25 Q4: $120M Revenue (TTM), FY26 Q4: $132.2M $132.2M

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Revenue (TTM)
FY20 Q4 $117.3M
FY21 Q4 $133.1M
FY22 Q4 $164.4M
FY23 Q4 $120.2M
FY24 Q4 $124M
FY25 Q4 $120M
FY26 Q4 $132.2M
Revenue growth, TTM YoY Ridgetech Inc.
-40% -20% 0% 20% 40% FY21 Q4 FY22 Q4 FY23 Q4 FY24 Q4 FY25 Q4 FY26 Q4 Revenue growth, TTM YoY, FY21 Q4: 13.5% Revenue growth, TTM YoY, FY22 Q4: 23.5% Revenue growth, TTM YoY, FY23 Q4: -26.9% Revenue growth, TTM YoY, FY24 Q4: 3.2% Revenue growth, TTM YoY, FY25 Q4: -3.2% Revenue growth, TTM YoY, FY26 Q4: 10.2% 10.2%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Revenue growth, TTM YoY
FY21 Q4 13.5%
FY22 Q4 23.5%
FY23 Q4 -26.9%
FY24 Q4 3.2%
FY25 Q4 -3.2%
FY26 Q4 10.2%
Operating margin (TTM) Ridgetech Inc.
-15% -10% -5% 0% 5% FY20 Q4 FY22 Q4 FY24 Q4 FY26 Q4 Operating margin (TTM), FY20 Q4: -6.0% Operating margin (TTM), FY21 Q4: -6.6% Operating margin (TTM), FY22 Q4: -1.6% Operating margin (TTM), FY23 Q4: -11.0% Operating margin (TTM), FY24 Q4: 0.5% Operating margin (TTM), FY25 Q4: -0.9% Operating margin (TTM), FY26 Q4: -1.4% -1.4%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Operating margin (TTM)
FY20 Q4 -6.0%
FY21 Q4 -6.6%
FY22 Q4 -1.6%
FY23 Q4 -11.0%
FY24 Q4 0.5%
FY25 Q4 -0.9%
FY26 Q4 -1.4%
FCF margin (TTM) Ridgetech Inc.
-8% -6% -4% -2% 0% 2% FY20 Q4 FY22 Q4 FY24 Q4 FY26 Q4 FCF margin (TTM), FY20 Q4: -6.4% FCF margin (TTM), FY21 Q4: -0.1% FCF margin (TTM), FY22 Q4: -3.3% FCF margin (TTM), FY23 Q4: -2.8% FCF margin (TTM), FY24 Q4: -2.8% FCF margin (TTM), FY25 Q4: 0.9% FCF margin (TTM), FY26 Q4: -1.1% -1.1%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period FCF margin (TTM)
FY20 Q4 -6.4%
FY21 Q4 -0.1%
FY22 Q4 -3.3%
FY23 Q4 -2.8%
FY24 Q4 -2.8%
FY25 Q4 0.9%
FY26 Q4 -1.1%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 20-F. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2020 Mar 2020 2021 Mar 2021 2022 Mar 2022 2023 Mar 2023 2024 Mar 2024 2025 Mar 2025 2026 Mar 2026
Income
Revenue 117 133 164 120 124 120 132
Gross profit 26 29 37 4 5 4 5
EBITDA −5 −7 −1 −12 1 0 −2
Operating income −7 −9 −3 −13 1 −1 −2
Net income −6 −8 −3 −21 −4 10 −1
Diluted EPS −$90.00 −$99.58 −$38.23 −$259.13 −$54.97 $137.94 −$17.21
Growth (year on year)
Revenue — +13.5% +23.5% −26.9% +3.2% −3.2% +10.2%
Net income — — — — — — −112.3%
Diluted EPS — — — — — — −112.5%
Margins
Gross margin 21.8% 22.0% 22.2% 3.0% 3.9% 3.2% 3.6%
EBITDA margin −4.2% −5.3% −0.9% −10.4% 1.1% 0.1% −1.1%
Operating margin −6.0% −6.6% −1.6% −11.0% 0.5% −0.9% −1.4%
Net margin −5.0% −6.1% −1.9% −17.6% −3.4% 8.5% −0.9%
Free-cash-flow margin −6.4% −0.1% −3.3% −2.8% −2.8% 0.9% −1.1%
Cash flow
Cash from operations −7 −0 −5 −3 −3 1 −1
Capital spending 1 0 0 0 0 0 0
Free cash flow −8 −0 −5 −3 −3 1 −1
Stock-based pay 0 4 — 10 — — —
Free cash flow after stock pay −8 −4 — −14 — — —
Balance sheet
Cash 31 22 18 19 2 13 18
Total debt 0 28 — 29 7 10 0
Net debt (negative = net cash) −31 6 −18 10 4 −2 −18
Diluted shares — — — — — — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 3 checks passed · March 31, 2026
What it owns · $69m
Short-term assets $65mLonger-term assets $4m
What it owes, and who funded it · $69m
Short-term liabilities $28mLonger-term liabilities $0mShareholders' equity $41m
  • Short-term assets cover short-term liabilities $65m of assets due within a year against $28m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $65m short-term assets against $356,353 of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of −$2m against $67,069 of interest.

From Ridgetech Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
+96.6%
year over year
Days sales outstanding
90 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in health care services
Last 12 months unless stated RDGT NRC AIRS PETS SBC DLHC Median
Revenue, last 12 months $132m $140m $151m $169m $175m $254m $1.2bn
Revenue growth, last 12 months 10.2% −0.2% −8.7% −20.3% −6.9% −29.5% 7.3%
Revenue growth, 3-year average — −1.9% −5.9% −13.0% — −9.5% 11.3%
Revenue growth, latest quarter — 4.0% −2.5% −19.9% 13.4% −46.9% 8.5%
Gross margin 3.6% — — 27.9% 71.9% 24.3% 27.9%
Operating margin −1.4% 10.5% −8.4% −18.2% 37.3% −0.1% 2.3%
Operating margin, 3-year average — 19.1% −3.0% −12.6% 37.3% 3.5% 2.3%
Net margin −0.9% 4.0% −7.8% −17.3% 28.0% −8.5% 1.2%
Cash from operations / revenue −1.1% 21.1% 0.8% −14.1% 35.9% 5.5% 6.1%
Free-cash-flow margin −1.1% 15.5% 0.5% −16.4% 35.3% 5.5% 5.1%
Free-cash-flow margin, 3-year average — 12.5% 0.6% −7.3% — 6.6% 3.6%
Stock pay / revenue 8.6% 8.4% 0.8% 0.6% — 0.5% 1.1%
Change in share count 96.6% −5.2% 13.3% 2.9% 1.4% 2.2% 0.3%

Median of all 41 companies we cover in health care services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

41 health care services companies
Measure Company Peer median Rank
Revenue growth Growth 10.2% 7.3% 17 of 41
Change in growth rate Growth +13.4pp +1.1pp 3 of 41
Gross margin Profitability 3.6% 29.0% 25 of 27
Operating margin Profitability -1.4% 2.6% 26 of 40
Net margin Profitability -0.9% 1.2% 25 of 41
Free-cash-flow margin Cash generation -1.1% 5.1% 30 of 40
Change in share count Balance sheet 96.6% 0.4% 37 of 39
Days sales outstanding Balance sheet 90 days 39 days 30 of 31

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$190,307
Institutions reporting
5
Positions opened / closed
5 / 0

Top buyers and sellers, Q2 2026: 5 institutions bought and 0 sold ; the biggest buyer was HRT Financial LP (+90K shares) . See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
HRT Financial LP $135,000 90K 70.9% —
Virtu Financial LLC $43,000 29K 22.6% —
UBS Group AG $12,101 8K 6.4% —
Hhlr Advisors, Ltd. $204 0K 0.1% —
Harbour Investments, Inc. $2 0K 0.0% —

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Ridgetech Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $161,241 5 trades by 1 insider, last 12 months Insider sales History → $115,597 3 trades by 1 insider · 0% under pre-set plans
Net ▲ $45,644 net buying
Insider Date Trade Shares Price Value
Hrt Financial Lp 10% owner July 1, 2026 Buy 10,197 $1.50 $15,296
Hrt Financial Lp 10% owner June 30, 2026 Buy 30,939 $1.52 $47,027
Hrt Financial Lp 10% owner June 16, 2026 Sell 57,998 $1.60 $92,797
Hrt Financial Lp 10% owner June 15, 2026 Sell 8,091 $1.60 $12,946
Hrt Financial Lp 10% owner June 12, 2026 Sell 6,526 $1.51 $9,854
Hrt Financial Lp 10% owner June 11, 2026 Buy 19,373 $1.61 $31,191
Hrt Financial Lp 10% owner June 10, 2026 Buy 14,312 $1.62 $23,185
Hrt Financial Lp 10% owner June 9, 2026 Buy 25,024 $1.78 $44,543

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Data status

When each part of this page on Ridgetech Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Ridgetech Inc. in brief

What does Ridgetech Inc. do?
Ridgetech Inc. is a US-listed company in the health care services industry. Its financial year ends in March.
What is Ridgetech Inc.'s stock ticker?
Ridgetech Inc. trades under the ticker RDGT on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Ridgetech Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Ridgetech Inc. reported revenue of $132M, 10.2% higher than a year earlier, according to its SEC filings.
What is Ridgetech Inc.'s free cash flow?
Ridgetech Inc.'s free-cash-flow margin is -1.1% of revenue over the trailing twelve months, ranking 30 of the 40 health care services companies we cover.
Who are Ridgetech Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are HRT Financial LP, Virtu Financial LLC and UBS Group AG. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Ridgetech Inc.'s market cap?
On March 31, 2026, Ridgetech Inc.'s market capitalisation was about $327,006 and net debt of -$17.9M. Market figures come from third-party market data and may be delayed.
Who are Ridgetech Inc.'s competitors?
In our Health Care Services peer group, the companies closest to Ridgetech Inc. are NRC Health, Airsculpt Technologies, Inc., Petmed Express Inc, SBC Medical Group Holdings Inc and DLH Holdings Corp. The side-by-side comparison below sets their revenue, margins and growth against Ridgetech Inc.'s.
Are insiders buying or selling Ridgetech Inc. stock?
Over the last 12 months, Ridgetech Inc.'s directors and officers reported 5 open-market purchases and 3 sales on Form 4. The insider trading page charts every trade.